文献速递肝病

胆管病中协调性细胞死亡通路的研究进展

Orchestrated cell death pathways in cholangiopathies.
PubMed 文献 · Gut · 2026-09-11

胆管病以进行性胆管损伤、胆管反应和纤维化为特征,凋亡、坏死性凋亡、焦亡、铁死亡和自噬依赖性细胞死亡等受调控细胞死亡通路在胆管细胞中以疾病和情境依赖方式被触发。这些通路通过共享分子节点形成整合性细胞死亡程序,且亚致死性死亡信号激活可维持胆管细胞功能障碍并推动疾病进展。现有治疗主要改善胆汁成分和生化指标,未直接靶向调控胆管细胞死亡的分子网络。

要点

  • 多种受调控细胞死亡通路在胆管病中交互形成整合性死亡程序如PANoptosis。
  • 亚致死性死亡信号激活可导致胆管细胞功能障碍并促进慢性疾病进展。
  • 现有药物未直接靶向胆管细胞死亡的分子网络,可能限制其抗纤维化效果。

核心结论

  • 胆管病中多种受调控细胞死亡通路通过共享分子节点形成整合性程序,亚致死性死亡信号与衰老关联可维持疾病进展。

研究设计与样本

  • 本文为综述,系统总结胆管病中受调控细胞死亡机制及相关概念与技术挑战。

主要发现

  • 凋亡、坏死性凋亡、焦亡、铁死亡和自噬依赖性细胞死亡可在胆管细胞中以疾病依赖和情境依赖方式触发。
  • 这些通路通过共享分子节点交互形成PANoptosis等整合性细胞死亡程序。
  • 亚致死性死亡信号激活可维持胆管细胞功能障碍并推动慢性疾病进展。

临床怎么用

  • 现有熊去氧胆酸和过氧化物酶体增殖物激活受体激动剂主要改善胆汁成分和生化指标,未直接靶向胆管细胞死亡分子网络。

局限性

  • 受调控细胞死亡机制的解释和治疗靶向面临概念和技术挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cholangiopathies comprise a heterogeneous group of chronic liver diseases characterised by progressive bile duct injury, ductular reaction and fibrotic remodelling. Despite distinct aetiologies, these disorders share common cellular stressors that ultimately converge on cholangiocyte dysfunction and loss. In this context, programmed cell death has emerged as a central mechanism linking epithelial stress, immune activation and the development of biliary fibrosis. A range of regulated cell death pathways, including apoptosis, necroptosis, pyroptosis, ferroptosis and autophagy-dependent cell death, can be triggered in cholangiocytes in a disease-dependent and context-dependent manner. Growing evidence suggests that these pathways rarely act in isolation. Instead, they intersect through shared molecular nodes, forming integrated cell death programmes such as PANoptosis. Importantly, it is becoming clear that not only overt cell death but also sublethal activation of death-related signalling can perpetuate cholangiocyte dysfunction and fuel chronic disease progression. Current therapeutic strategies, such as ursodeoxycholic acid and peroxisome proliferator-activated receptor agonists, mainly aim to modify bile composition and improve biochemical parameters. However, they do not directly target the molecular networks governing cholangiocyte death, which may partly explain their limited impact on fibrosis and long-term outcomes. In this review, we synthesise current knowledge on regulated cell death mechanisms in cholangiopathies, highlight key conceptual and technical challenges that complicate their interpretation and therapeutic targeting, and discuss how sublethal death signalling may connect with senescence to sustain cholangiopathy progression and shape therapeutic perspectives.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Guicciardi ME, Pistorio V, Soret PA, et al. Orchestrated cell death pathways in cholangiopathies. Gut. 2026. PMID: 42728026. doi:10.1136/gutjnl-2026-339264

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。